PRReleasevia Quantisnow
Phathom Pharmaceuticals Inc. logo

Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for PHAT

Across the 9 sessions after earlier PHAT headlines, the stock closed higher 4 times and lower 5 times, with a median move of 1.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

Keep researching PHAT

Quantisnow market dataNASDAQ
Phathom Pharmaceuticals Inc. logo
PHAT
Phathom Pharmaceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2019
Get push alerts for PHAT

Follow PHAT and get a push notification the moment its next story breaks.

Full PHAT profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHAT (Phathom Pharmaceuticals Inc.) and more on Quantisnow.